Resultados de procura - Ling, John
- Mostrando 1 - 14 Resultados de 14
-
1
-
2
-
3
Supporting self‐management after traumatic brain injury: Codesign and evaluation of a new intervention across a trauma pathway por Mäkelä, Petra, Jones, Fiona, de Sousa de Abreu, Maria Inês, Hollinshead, Lucinda, Ling, John
Publicado 2019Text -
4
-
5
Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID‐19, in Healthy Subjects por Humeniuk, Rita, Mathias, Anita, Cao, Huyen, Osinusi, Anu, Shen, Gong, Chng, Estelle, Ling, John, Vu, Amanda, German, Polina
Publicado 2020Text -
6
-
7
Lack of clinically important PK interaction between coformulated ledipasvir/sofosbuvir and rilpivirine/emtricitabine/tenofovir alafenamide por Custodio, Joseph M., Chuck, Susan K., Chu, Hoa, Cao, Huyen, Ma, Grace, Flaherty, John, Ling, John, Kearney, Brian P.
Publicado 2017Text -
8
Cytochrome P450 3A Induction Predicts P‐glycoprotein Induction; Part 1: Establishing Induction Relationships Using Ascending Dose Rifampin por Lutz, Justin D., Kirby, Brian J., Wang, Lu, Song, Qinghua, Ling, John, Massetto, Benedetta, Worth, Angela, Kearney, Brian P., Mathias, Anita
Publicado 2018Text -
9
Cytochrome P450 3A Induction Predicts P‐glycoprotein Induction; Part 2: Prediction of Decreased Substrate Exposure After Rifabutin or Carbamazepine por Lutz, Justin D., Kirby, Brian J., Wang, Lu, Song, Qinghua, Ling, John, Massetto, Benedetta, Worth, Angela, Kearney, Brian P., Mathias, Anita
Publicado 2018Text -
10
Diurnal Variability in Orthostatic Tachycardia: Implications for Postural Tachycardia Syndrome por Brewster, Jordan A, Garland, Emily M., Biaggioni, Italo, Black, Bonnie K, Ling, John F, Shibao, Cyndya A, Robertson, David, Raj, Satish R
Publicado 2012Text -
11
Ulysses - an application for the projection of molecular interactions across species por Kemmer, Danielle, Huang, Yong, Shah, Sohrab P, Lim, Jonathan, Brumm, Jochen, Yuen, Macaire MS, Ling, John, Xu, Tao, Wasserman, Wyeth W, Ouellette, BF Francis
Publicado 2005Text -
12
Preclinical Pharmacokinetics and First-in-Human Pharmacokinetics, Safety, and Tolerability of Velpatasvir, a Pangenotypic Hepatitis C Virus NS5A Inhibitor, in Healthy Subjects por Mogalian, Erik, German, Polina, Kearney, Brian P., Yang, Cheng Yong, Brainard, Diana, Link, John, McNally, John, Han, LingLing, Ling, John, Mathias, Anita
Publicado 2017Text -
13
Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor por Humeniuk, Rita, Mathias, Anita, Kirby, Brian J., Lutz, Justin D., Cao, Huyen, Osinusi, Anu, Babusis, Darius, Porter, Danielle, Wei, Xuelian, Ling, John, Reddy, Y. Sunila, German, Polina
Publicado 2021Text -
14
Clinical targeting of HIV capsid protein with a long-acting small molecule por Link, John O., Rhee, Martin S., Tse, Winston C., Zheng, Jim, Somoza, John R., Rowe, William, Begley, Rebecca, Chiu, Anna, Mulato, Andrew, Hansen, Derek, Singer, Eric, Tsai, Luong K., Bam, Rujuta A., Chou, Chien-Hung, Canales, Eda, Brizgys, Gediminas, Zhang, Jennifer R., Li, Jiayao, Graupe, Michael, Morganelli, Philip, Liu, Qi, Wu, Qiaoyin, Halcomb, Randall L., Saito, Roland D., Schroeder, Scott D., Lazerwith, Scott E., Bondy, Steven, Jin, Debi, Hung, Magdeleine, Novikov, Nikolai, Liu, Xiaohong, Villaseñor, Armando G., Cannizzaro, Carina E., Hu, Eric Y., Anderson, Robert L., Appleby, Todd C., Lu, Bing, Mwangi, Judy, Liclican, Albert, Niedziela-Majka, Anita, Papalia, Giuseppe A., Wong, Melanie H., Leavitt, Stephanie A., Xu, Yili, Koditek, David, Stepan, George J., Yu, Helen, Pagratis, Nikos, Clancy, Sheila, Ahmadyar, Shekeba, Cai, Terrence Z., Sellers, Scott, Wolckenhauer, Scott A., Ling, John, Callebaut, Christian, Margot, Nicolas, Ram, Renee R., Liu, Ya-Pei, Hyland, Rob, Sinclair, Gary I., Ruane, Peter J., Crofoot, Gordon E., McDonald, Cheryl K., Brainard, Diana M., Lad, Latesh, Swaminathan, Swami, Sundquist, Wesley I., Sakowicz, Roman, Chester, Anne E., Lee, William E., Daar, Eric S., Yant, Stephen R., Cihlar, Tomas
Publicado 2020Text